Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
10
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Burch Richard Alan | Director | 4 | $0 | $0 | 2024-02-26 |
| Duncan Gregory Scott | Chief Executive Officer | 15 | $288.6K | $0 | 2024-02-26 |
| Gendreau Roger Michael | Chief Medical Officer | 4 | $0 | $0 | 2024-02-26 |
| Pridgen William | Director | 17 | $231.9K | $0 | 2024-02-26 |
| Grosswald Ralph | Vice President of Operations | 6 | $0 | $0 | 2024-02-26 |
| Walsh Angela | VP of Finance | 8 | $16.5K | $0 | 2024-02-26 |
| Keefer David R | Director | 7 | $29.0K | $0 | 2024-02-26 |
| De La Rosa Abel | Director | 5 | $23.6K | $0 | 2024-02-26 |
| Whitley Richard James | Director | 8 | $13.7K | $468 | 2024-02-26 |
| Thomas John C | Director | 5 | $5.7K | $0 | 2024-02-26 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award deriv | 2024-02-26 | 2024-02-28 | 138,835 | — | $0 | 138,835 | SEC↗ |
| Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award deriv | 2024-02-26 | 2024-02-28 | 88,085 | — | $0 | 88,085 | SEC↗ |
| Grosswald Ralph | SVP OF OPERATIONS | A Award deriv | 2024-02-26 | 2024-02-28 | 62,568 | — | $0 | 62,568 | SEC↗ |
| Walsh Angela | SVP OF FINANCE | A Award deriv | 2024-02-26 | 2024-02-28 | 63,618 | — | $0 | 63,618 | SEC↗ |
| De La Rosa Abel | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 3,959 | — | $0 | 3,959 | SEC↗ |
| Burch Richard Alan | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 2,917 | — | $0 | 2,917 | SEC↗ |
| Keefer David R | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 4,709 | — | $0 | 4,709 | SEC↗ |
| Whitley Richard James | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 4,000 | — | $0 | 4,000 | SEC↗ |
| Thomas John C | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 4,167 | — | $0 | 4,167 | SEC↗ |
| Pridgen William | Director | A Award deriv | 2024-02-26 | 2024-02-28 | 2,917 | — | $0 | 2,917 | SEC↗ |
| Pridgen William | Director | P Buy | 2023-08-21 | 2023-08-22 | 15,335 | $1.30 | $19.9K | 52,045 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | P Buy | 2023-08-17 | 2023-08-18 | 25,000 | $1.25 | $31.3K | 57,461 | SEC↗ |
| Pridgen William | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Whitley Richard James | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Burch Richard Alan | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Thomas John C | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| De La Rosa Abel | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Keefer David R | Director | A Award deriv | 2023-06-15 | 2023-06-20 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-12-12 | 2023-02-15 | 410,000 | — | $0 | 410,000 | SEC↗ |
| Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award deriv | 2022-12-12 | 2022-12-14 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Grosswald Ralph | SVP OF OPERATIONS | A Award deriv | 2022-12-12 | 2022-12-14 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Walsh Angela | SVP OF FINANCE | A Award deriv | 2022-12-12 | 2022-12-14 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-12-12 | 2022-12-14 | 480,000 | — | $0 | 480,000 | SEC↗ |
| Whitley Richard James | Director | S Sale | 2022-12-08 | 2022-12-12 | 1,800 | $0.26 | $468 | 700 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award deriv | 2022-06-23 | 2022-06-30 | 90,000 | — | $0 | 90,000 | SEC↗ |
| Walsh Angela | SVP OF FINANCE | A Award deriv | 2022-06-23 | 2022-06-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Grosswald Ralph | SVP OF OPERATIONS | A Award deriv | 2022-06-23 | 2022-06-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| Gendreau Roger Michael | CHIEF MEDICAL OFFICER | A Award deriv | 2022-06-23 | 2022-06-30 | 40,000 | — | $0 | 40,000 | SEC↗ |
| De La Rosa Abel | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Thomas John C | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Keefer David R | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Burch Richard Alan | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Pridgen William | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Whitley Richard James | Director | A Award deriv | 2022-06-23 | 2022-06-30 | 5,250 | — | $0 | 5,250 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | P Buy | 2022-05-23 | 2022-05-24 | 7,500 | $4.52 | $33.9K | 32,461 | SEC↗ |
| Walsh Angela | SVP OF FINANCE | P Buy | 2022-05-23 | 2022-05-24 | 2,000 | $4.58 | $9.2K | 3,000 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-05-18 | 2022-05-19 | 241 | $4.50 | $1.1K | 36,710 | SEC↗ |
| Whitley Richard James | Director | P Buy | 2022-05-18 | 2022-05-19 | 500 | $4.53 | $2.3K | 2,500 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-05-17 | 2022-05-18 | 13,450 | $4.38 | $58.9K | 36,469 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-03-29 | 2022-03-30 | 600 | $4.94 | $3.0K | 23,019 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-03-23 | 2022-03-24 | 2,197 | $5.46 | $12.0K | 22,419 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-01-27 | 2022-01-28 | 4,180 | $5.98 | $25.0K | 18,722 | SEC↗ |
| De La Rosa Abel | Director | P Buy | 2022-01-07 | 2022-01-07 | 4,000 | $5.90 | $23.6K | 4,000 | SEC↗ |
| Whitley Richard James | Director | P Buy | 2022-01-06 | 2022-01-07 | 1,800 | $5.72 | $10.3K | 2,000 | SEC↗ |
| Thomas John C | Director | P Buy | 2022-01-04 | 2022-01-04 | 1,000 | $5.65 | $5.7K | 1,000 | SEC↗ |
| Keefer David R | Director | P Buy | 2022-01-04 | 2022-01-05 | 5,000 | $5.80 | $29.0K | 5,000 | SEC↗ |
| Pridgen William | Director | P Buy | 2022-01-03 | 2022-01-04 | 2,215 | $5.43 | $12.0K | 14,542 | SEC↗ |
| Whitley Richard James | Director | P Buy | 2021-12-23 | 2021-12-23 | 200 | $5.73 | $1.1K | 200 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | P Buy | 2021-12-21 | 2021-12-22 | 5,000 | $5.52 | $27.6K | 24,961 | SEC↗ |
| Pridgen William | Director | P Buy | 2021-12-21 | 2021-12-22 | 8,827 | $5.66 | $50.0K | 12,327 | SEC↗ |
| Pridgen William | Director | P Buy | 2021-07-07 | 2021-07-09 | 942 | $6.32 | $6.0K | 710,734 | SEC↗ |
| De La Rosa Abel | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Keefer David R | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Thomas John C | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Whitley Richard James | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Burch Richard Alan | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Pridgen William | Director | A Award deriv | 2021-06-22 | 2021-06-23 | 7,875 | — | $0 | 7,875 | SEC↗ |
| Duncan Gregory Scott | CHIEF EXECUTIVE OFFICER | A Award deriv | 2021-06-21 | 2021-06-22 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Grosswald Ralph | VICE PRESIDENT OF OPERATIONS | A Award deriv | 2021-06-21 | 2021-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Walsh Angela | SVP OF FINANCE | A Award deriv | 2021-06-21 | 2021-06-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | P Buy | 2021-04-06 | 2021-04-07 | 382 | $6.36 | $2.4K | 19,961 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | P Buy | 2021-04-05 | 2021-04-06 | 15,675 | $6.17 | $96.7K | 19,579 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | P Buy | 2021-04-05 | 2021-04-06 | 15,675 | $6.17 | $96.7K | 19,579 | SEC↗ |
| Pridgen William | Director | P Buy | 2021-01-29 | 2021-02-01 | 3,500 | $7.47 | $26.1K | 3,500 | SEC↗ |
| Keefer David R | Director | M Exercise deriv | 2021-01-28 | 2021-02-01 | 1,602 | — | $0 | 0 | SEC↗ |
| Pridgen William | Director | M Exercise deriv | 2021-01-28 | 2021-02-01 | 801 | — | $0 | 0 | SEC↗ |
| Keefer David R | Director | M Exercise | 2021-01-28 | 2021-02-01 | 1,602 | $7.80 | $12.5K | 7,808 | SEC↗ |
| Pridgen William | Director | M Exercise | 2021-01-28 | 2021-02-01 | 801 | $7.80 | $6.2K | 727,993 | SEC↗ |
| Walsh Angela | VP of Finance | P Buy | 2021-01-28 | 2021-02-01 | 1,000 | $7.30 | $7.3K | 1,000 | SEC↗ |
| Walsh Angela | VP of Finance | A Award deriv | 2021-01-11 | 2021-01-12 | 209 | — | $0 | 41,621 | SEC↗ |
| Grosswald Ralph | VP of Finance | A Award deriv | 2021-01-11 | 2021-01-12 | 209 | — | $0 | 41,621 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | A Award deriv | 2021-01-11 | 2021-01-12 | 21,796 | — | $0 | 435,921 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | M Exercise deriv | 2021-01-06 | 2021-01-08 | 801 | — | $0 | 0 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | M Exercise | 2021-01-06 | 2021-01-08 | 801 | $7.80 | $6.2K | 3,904 | SEC↗ |
| Gendreau Roger Michael | Chief Medical Officer | A Award deriv | 2021-01-01 | 2021-01-12 | 41,734 | — | $0 | 41,734 | SEC↗ |
| Walsh Angela | VP of Finance | A Award deriv | 2020-12-21 | 2020-12-21 | 41,412 | — | $0 | 41,412 | SEC↗ |
| Grosswald Ralph | Vice President of Operations | A Award deriv | 2020-12-21 | 2020-12-21 | 41,412 | — | $0 | 41,412 | SEC↗ |
| Duncan Gregory Scott | Chief Executive Officer | A Award deriv | 2020-12-21 | 2020-12-21 | 414,125 | — | $0 | 414,125 | SEC↗ |
| Pridgen William | Director | P Buy | 2020-12-17 | 2020-12-21 | 1,500 | $11.98 | $18.0K | 727,192 | SEC↗ |